Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cbd Life Sciences Inc (CBDL)

Cbd Life Sciences Inc (CBDL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0004 +25.00%
on 03/27/20
0.0009 -44.44%
on 03/20/20
unch (unch)
since 02/27/20
3-Month
0.0004 +25.00%
on 03/27/20
0.0024 -79.17%
on 01/21/20
-0.0012 (-70.59%)
since 12/27/19
52-Week
0.0004 +25.00%
on 03/27/20
0.0684 -99.27%
on 06/24/19
-0.0163 (-97.02%)
since 03/27/19

Most Recent Stories

More News
CBD Life Sciences Subsidiary LBC Bioscience Launches First CBD Proprietary Tablet

SCOTTSDALE, AZ / ACCESSWIRE / March 25, 2020 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC BIO" is pleased to announce in addition to our two stores...

CBDL : 0.0005 (unch)
LBC Bioscience to Open Retail Kiosk at Prestigious Scottsdale Fashion Square Mall

SCOTTSDALE, AZ / ACCESSWIRE / March 12, 2020 / CBD Life Sciences Inc. (OTCPINK:CBDL) through its wholly owned subsidiary, LBC Bioscience "LBC Bio" is pleased to announce the near term opening of their...

CBDL : 0.0005 (unch)
CBD Life Sciences Subsidiary to Launch Natural Hemp CBD Gummies Product Line

EQNX::TICKER_START (PinkSheets:CBDL), EQNX::TICKER_END

CBDL : 0.0005 (unch)
CBD Life Sciences Subsidiary in Talks to Acquire Land for Commercial Hemp Growing Operation

via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) today announced that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC Bioscience), has entered into negotiations to acquire a parcel of land...

CBDL : 0.0005 (unch)
CBD Life Sciences Files Initial Reg A+ Offering Statement

via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that it has filed an offering statement with the United States Securities Exchange Commission (SEC) to raise $10 million under...

CBDL : 0.0005 (unch)
CBD Life Sciences Subsidiary Developing Line of CBD Based Coffee Products Including Weight Loss Coffee & Brain Booster

via NEWMEDIAWIRE - CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, Inc. (LBC), has finalized the development and is preparing to launch a CBD...

CBDL : 0.0005 (unch)
CBD Life Sciences Subsidiary Launches Product for Equine Market

via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, has completed its formulation and is now marketing a CBD supplement for the...

CBDL : 0.0005 (unch)
CBD Life Sciences Subsidiary Enters Into Negotiations to Enter Japanese Market

via NEWMEDIAWIRE -- CBD Life Sciences Inc. (OTC:CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience has entered into negotiations to distribute its line of products in Japan....

CBDL : 0.0005 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CBDL with:

Key Turning Points

2nd Resistance Point 0.0007
1st Resistance Point 0.0006
Last Price 0.0005
1st Support Level 0.0004
2nd Support Level 0.0003

See More

52-Week High 0.0684
Fibonacci 61.8% 0.0424
Fibonacci 50% 0.0344
Fibonacci 38.2% 0.0264
Last Price 0.0005
52-Week Low 0.0004

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar